Perfromance Wealth Partners’s Ecolab ECL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$472K Sell
1,776
-101
-5% -$28.5K 0.01% 128
2025
Q4
$493K Sell
1,877
-1,087
-37% -$290K 0.01% 124
2025
Q3
$812K Sell
2,964
-71
-2% -$19.3K 0.02% 87
2025
Q2
$818K Sell
3,035
-65
-2% -$16.5K 0.03% 79
2025
Q1
$786K Buy
3,100
+3
+0.1% +$756 0.03% 69
2024
Q4
$726K Buy
3,097
+43
+1% +$10.7K 0.02% 78
2024
Q3
$780K Buy
3,054
+1,744
+133% +$427K 0.03% 71
2024
Q2
$312K Hold
1,310
0.01% 119
2024
Q1
$302K Hold
1,310
0.01% 127
2023
Q4
$260K Hold
1,310
0.01% 142
2023
Q3
$222K Hold
1,310
0.01% 152
2023
Q2
$241K Sell
1,310
-273
-17% -$47K 0.01% 160
2023
Q1
$262K Buy
+1,583
New +$247K 0.01% 156
2022
Q4
Sell
-4,903
Closed -$708K 168
2022
Q3
$708K Sell
4,903
-345
-7% -$56K 0.04% 81
2022
Q2
$807K Sell
5,248
-693
-12% -$115K 0.05% 78
2022
Q1
$1.05M Sell
5,941
-1,191
-17% -$224K 0.05% 74
2021
Q4
$1.67M Buy
+7,132
New +$1.61M 0.07% 61

Other funds holding ECL

Perfromance Wealth Partners's ECL Position: Q1 2026 in Review

Perfromance Wealth Partners reduced its Ecolab (ECL) stake by 5.4% in Q1 2026, selling an estimated $28.5K and leaving 1,776 shares worth $472K. The position accounts for 0.01% of the portfolio, ranked #128.

Perfromance Wealth Partners first reported a position in ECL in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.67M in Q4 2021. 1,691 funds tracked by Wall St. Rank hold ECL as of Q1 2026.

  • Perfromance Wealth Partners held 1,776 shares of Ecolab worth $472K as of Q1 2026.
  • Perfromance Wealth Partners sold 101 Ecolab shares in Q1 2026, an estimated $28.5K.
  • Ecolab made up 0.01% of Perfromance Wealth Partners's portfolio in Q1 2026, its #128 holding.
  • Perfromance Wealth Partners first reported a position in Ecolab in Q4 2021 and has held it in 17 quarters since.
  • Perfromance Wealth Partners's Ecolab position peaked at $1.67M in Q4 2021.
  • 1,691 funds tracked by Wall St. Rank held Ecolab as of Q1 2026.

Based on Perfromance Wealth Partners's 13F filing for Q1 2026, filed 10 Apr 2026.